"Bucladesine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
| Descriptor ID |
D003994
|
| MeSH Number(s) |
D03.633.100.759.646.138.395.250 D13.695.462.200.250 D13.695.667.138.395.250 D13.695.827.068.395.250
|
| Concept/Terms |
Bucladesine- Bucladesine
- Dibutyryl Adenosine 3,5 Monophosphate
- Dibutyryl Adenosine-3',5'-Monophosphate
- Adenosine-3',5'-Monophosphate, Dibutyryl
- Dibutyryl Adenosine 3',5' Monophosphate
- DBcAMP
- N',O'-Dibutyryl-cAMP
- N',O' Dibutyryl cAMP
- N(6),0(2')-Dibutyryl Cyclic AMP
- (But)(2) cAMP
- Dibutyryl Cyclic AMP
- AMP, Dibutyryl Cyclic
- Cyclic AMP, Dibutyryl
|
Below are MeSH descriptors whose meaning is more general than "Bucladesine".
Below are MeSH descriptors whose meaning is more specific than "Bucladesine".
This graph shows the total number of publications written about "Bucladesine" by people in this website by year, and whether "Bucladesine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bucladesine" by people in Profiles.
-
Zaidi SK, Shen WJ, Bittner S, Bittner A, McLean MP, Han J, Davis RJ, Kraemer FB, Azhar S. p38 MAPK regulates steroidogenesis through transcriptional repression of STAR gene. J Mol Endocrinol. 2014 Aug; 53(1):1-16.
-
Hsu PY, Kotin RM, Yang YW. Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharm Res. 2008 Jun; 25(6):1460-8.
-
Jha KN, Salicioni AM, Arcelay E, Chertihin O, Kumari S, Herr JC, Visconti PE. Evidence for the involvement of proline-directed serine/threonine phosphorylation in sperm capacitation. Mol Hum Reprod. 2006 Dec; 12(12):781-9.
-
Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab. 2002 Sep; 87(9):4166-70.
-
Mitra SP, Carraway RE. Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells. Biochem Pharmacol. 1999 Jun 15; 57(12):1391-7.
-
Visconti PE, Moore GD, Bailey JL, Leclerc P, Connors SA, Pan D, Olds-Clarke P, Kopf GS. Capacitation of mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are regulated by a cAMP-dependent pathway. Development. 1995 Apr; 121(4):1139-50.
-
Mullikin-Kilpatrick D, Treistman SN. Time course of nerve growth factor modulation of ethanol inhibition of Ca2+ currents in PC12 cells. Neurosci Lett. 1994 Jul 18; 176(1):101-4.
-
Chang CH, Chey WY, Sun Q, Leiter A, Chang TM. Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1. Biochim Biophys Acta. 1994 Apr 28; 1221(3):339-47.